Radio and PodcastRadio and PodcastLive Radio & Podcasts
Episode 505: A Breakthrough in Cholesterol Care With an Oral PCSK9 Inhibitor artwork
Health

Episode 505: A Breakthrough in Cholesterol Care With an Oral PCSK9 Inhibitor

Heart Doc VIP with Dr. Joel Kahn by Dr. Joel Kahn

Jul 21, 202623:30Health

This week, Dr. Kahn discusses the FDA approval of the first oral PCSK9 inhibitor, Lipfendra (enclicitide), taken as a 20 mg daily tablet. In a study of nearly 3,000 patients with elevated LDL cholesterol despite treatmen...

About This Episode

Episode 505: A Breakthrough in Cholesterol Care With an Oral PCSK9 Inhibitor is an episode from Heart Doc VIP with Dr. Joel Kahn by Dr. Joel Kahn. This week, Dr. Kahn discusses the FDA approval of the first oral PCSK9 inhibitor, Lipfendra (...

Podcast

This episode belongs to Heart Doc VIP with Dr. Joel Kahn.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jul 21, 2026, 23:30 long, audio available.

Related Episodes

Continue listening to more episodes from Heart Doc VIP with Dr. Joel Kahn.